GENO — Genovis AB Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapHigh Flyer

Annual income statement for Genovis AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	61	93	102	158	130
Cost of Revenue
Gross Profit	38.9	59.3	59.7	114	84.1
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	57.9	68.5	94.1	104	84.6
Operating Profit	3.14	24.5	8.28	54.2	45.7
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	2.15	24.6	8	54.9	46.3
Provision for Income Taxes
Net Income After Taxes	6.45	24.8	11.2	61.5	32.9
Net Income Before Extraordinary Items
Net Income	6.45	24.8	11.2	61.5	32.9
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	6.45	24.8	11.2	61.5	32.9
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.126	0.381	0.259	0.939	0.503
Dividends per Share